Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
Clarus Therapeutics Holdings Inc
Common Stock
Clarus Therapeutics Holdings Inc
Common Stock Peer Comparison
Competitive Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
|
Common Stock
$2k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Johnson & Johnson
NYSE:JNJ
|
Common Stock
$3.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Common Stock
$292m
|
CAGR 3-Years
0%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
Pfizer Inc
NYSE:PFE
|
Common Stock
$480m
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Merck & Co Inc
NYSE:MRK
|
Common Stock
$1.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Eli Lilly and Co
NYSE:LLY
|
Common Stock
$594.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
See Also
What is Clarus Therapeutics Holdings Inc's Common Stock?
Common Stock
2k
USD
Based on the financial report for Dec 31, 2021, Clarus Therapeutics Holdings Inc's Common Stock amounts to 2k USD.
What is Clarus Therapeutics Holdings Inc's Common Stock growth rate?
Common Stock CAGR 1Y
-100%
Over the last year, the Common Stock growth was -100%.